Similarly, the anti-oxidant effect of the HO system was amongst the mechanisms conferred protection against nonalcoholic fatty liver disease in mice and humans [61], [62]. This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatotic liver disease.